These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2791340)

  • 1. Characterization of the serologic profile of children with human immunodeficiency virus infection: correlation with clinical status.
    Kamani N; Krilov LR; Wittek AE; Hendry RM
    Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 1):233-42. PubMed ID: 2791340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type I.
    Böttiger B; Ljunggren K; Karlsson A; Krohn K; Fenyö EM; Jondal M; Biberfeld G
    Clin Exp Immunol; 1988 Sep; 73(3):339-42. PubMed ID: 3208445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 neutralizing antibodies in urine from seropositive individuals.
    Cao YZ; Friedman-Kien AE; Mirabile M; Li XL; Alam M; Dieterich D; Ho DD
    J Acquir Immune Defic Syndr (1988); 1990; 3(3):195-9. PubMed ID: 1968094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of serum neutralization response to the human immunodeficiency virus (HIV).
    Groopman JE; Benz PM; Ferriani R; Mayer K; Allan JD; Weymouth LA
    AIDS Res Hum Retroviruses; 1987; 3(1):71-85. PubMed ID: 2441727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of human immunodeficiency virus (HIV) p24 antigenemia with decrease in CD4+ lymphocytes and onset of acquired immunodeficiency syndrome during the early phase of HIV infection.
    Rinaldo C; Kingsley L; Neumann J; Reed D; Gupta P; Lyter D
    J Clin Microbiol; 1989 May; 27(5):880-4. PubMed ID: 2501352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing antibodies as a prognostic indicator in the progression of acquired immune deficiency syndrome (AIDS)-related disorders: a double-blind study.
    Sei Y; Tsang PH; Roboz JP; Sarin PS; Wallace JI; Bekesi JG
    J Clin Immunol; 1988 Nov; 8(6):464-72. PubMed ID: 3146584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive markers for the acquired immunodeficiency syndrome (AIDS) in hemophiliacs: persistence of p24 antigen and low T4 cell count.
    Eyster ME; Ballard JO; Gail MH; Drummond JE; Goedert JJ
    Ann Intern Med; 1989 Jun; 110(12):963-9. PubMed ID: 2567142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between HTLV-III neutralizing antibody and clinical status of pediatric acquired immunodeficiency syndrome (AIDS) and AIDS-related complex cases.
    Robert-Guroff M; Oleske JM; Connor EM; Epstein LG; Minnefor AB; Gallo RC
    Pediatr Res; 1987 Jun; 21(6):547-50. PubMed ID: 3474582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages.
    Ljunggren K; Broliden PA; Morfeldt-Månson L; Jondal M; Wahren B
    Clin Exp Immunol; 1988 Sep; 73(3):343-7. PubMed ID: 3208446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody specificity for human immunodeficiency virus type 1 in serum and cerebrospinal fluid from patients with AIDS and AIDS-related complex.
    Willoughby PB; Midgett JS; Folds JD
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1031-7. PubMed ID: 2482809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers.
    Ljunggren K; Moschese V; Broliden PA; Giaquinto C; Quinti I; Fenyö EM; Wahren B; Rossi P; Jondal M
    J Infect Dis; 1990 Feb; 161(2):198-202. PubMed ID: 2299204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological significance of the antibody response to HIV antigens expressed on the cell surface.
    Goudsmit J; Ljunggren K; Smit L; Jondal M; Fenyö EM
    Arch Virol; 1988; 103(3-4):189-206. PubMed ID: 3265052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].
    Sorice F; Vullo V; Cirelli A; Catania S; Mastroianni CM; Contini C; Delia S
    Boll Ist Sieroter Milan; 1989; 68(2):115-21. PubMed ID: 2562362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection.
    Sawyer LA; Katzenstein DA; Hendry RM; Boone EJ; Vujcic LK; Williams CC; Zeger SL; Saah AJ; Rinaldo CR; Phair JP
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):341-56. PubMed ID: 1971182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages.
    Ljunggren K; Böttiger B; Biberfeld G; Karlson A; Fenyö EM; Jondal M
    J Immunol; 1987 Oct; 139(7):2263-7. PubMed ID: 3498755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1-infected mothers and their children.
    Broliden K; Sievers E; Tovo PA; Moschese V; Scarlatti G; Broliden PA; Fundaro C; Rossi P
    Clin Exp Immunol; 1993 Jul; 93(1):56-64. PubMed ID: 8324904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenemia and antibody titers to core and envelope antigens in AIDS, AIDS-related complex, and subclinical human immunodeficiency virus infection.
    Goudsmit J; Lange JM; Paul DA; Dawson GJ
    J Infect Dis; 1987 Mar; 155(3):558-60. PubMed ID: 3468176
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitation of HIV: correlation with clinical, virological, and immunological status.
    O'Shea S; Rostron T; Hamblin AS; Palmer SJ; Banatvala JE
    J Med Virol; 1991 Sep; 35(1):65-9. PubMed ID: 1940886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring human immunodeficiency virus type 1-infected patients by ratio of antibodies to gp41 and p24.
    Schmidt G; Amiraian K; Frey H; Wethers J; Stevens RW; Berns DS
    J Clin Microbiol; 1989 May; 27(5):843-8. PubMed ID: 2501350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing and complement-dependent enhancing antibodies in different stages of HIV infection.
    Tóth FD; Szabó B; Ujhelyi E; Pálóczi K; Horváth A; Füst G; Kiss J; Bánhegyi D; Hollán SR
    AIDS; 1991 Mar; 5(3):263-8. PubMed ID: 1676275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.